CPT code 83516 represents a technical immunoassay laboratory procedure used to detect and semiquantitatively measure a noninfectious analyte. As a common laboratory service, it matters nationally because immunoassays inform diagnosis, monitoring, and treatment decisions across many clinical specialties. The code captures the technical component performed by lab personnel and yields results reported as positive/negative or in semiquantitative numerical form, which affects clinical interpretation and billing classification.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a consolidated overview of how CPT code 83516 is defined, typical sites of service where it is performed, and the clinical context in which results are reported. The publication also summarizes benchmarks and policy-relevant considerations related to laboratory coding and payment for immunoassays, and highlights practical billing elements such as common modifiers and the service line context.

This national summary is intended to orient billing managers, laboratory directors, and policy analysts to the clinical function and billing identity of CPT code 83516, and to clarify what information is available and what is not provided in the input data.